SCHEMBL630620

SCHEMBL630620

O=C(CC(O)(CC(=O)OC(=O)C(O)CO)C(=O)OC(=O)C(O)CO)OC(=O)C(O)CO

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12988284 0.93 ALDH1A1 (0.35) OR51E2
SCHEMBL4889099 0.79
SCHEMBL11232422 0.77 LMNA (0.43)
SCHEMBL924494 0.75 NAAA (0.44)
SCHEMBL1038853 0.75 NAAA (0.48)
SCHEMBL236695 0.73 OR51E2 (0.42) OR51E2
SCHEMBL8202199 0.73 OR51E2 (0.42) OR51E2
SCHEMBL21111027 0.73
SCHEMBL265908 0.73 OR51E2 (0.46) OR51E2
SCHEMBL93977 0.72 OR51E2 (0.50) OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 678 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137651-A1 MULTI-COMPARTMENT NANOEMULSION FOR INTRANASAL DRUG DELIVERY KING ABDULAZIZ UNIVERSITY (SA) 2026-05-21 US claimed
US-12599572-B2 Solid lipid nanoparticles of curcumin Punjab University Chandigarh (IN) 2026-04-14 US claimed
EP-4100001-B1 CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF I MED S COOP (ES) 2025-06-25 EP claimed
CN-119709306-B Antiwear lubricating grease composition and preparation method thereof 湖北博达特种润滑剂有限公司 2025-06-24 CN claimed
CN-119969502-A Fermented preparation in feed production process and preparation process thereof 北京都润科技有限公司 2025-05-13 CN claimed
CN-119709306-A Antiwear lubricating grease composition and preparation method thereof 湖北博达特种润滑剂有限公司 2025-03-28 CN claimed
US-20250098706-A1 MARBLED MEAT ANALOG AND METHODS OF MAKING MOTIF FOODWORKS INC (US) 2025-03-27 US claimed
CN-119404853-A Mosquito-repellent composition, mosquito-repellent emulsion and preparation method thereof 上海丽泓生物科技有限公司 2025-02-11 CN claimed
EP-4468875-A2 MARBLED MEAT ANALOG AND METHODS OF MAKING Motif Foodworks, Inc. (US) 2024-12-04 EP claimed
US-20240307352-A1 SACUBITRIL VALSARTAN SODIUM SUSTAINED-RELEASE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI AURORA BIOTECHNOLOGY CO., LTD. (CN) 2024-09-19 US claimed
US-20190240127-A1 COSMETIC ANTI-BLEMISH COMPOSITION, USE OF THE COMPOSITION AND METHOD FOR ANTI-BLEMISH TREATMENT Natura Cosméticos S.A. (BR) 2019-08-08 US claimed
EP-3501494-A1 COSMETIC ANTI-BLEMISH COMPOSITION, USE OF THE COMPOSITION AND METHOD FOR ANTI-BLEMISH TREATMENT Natura Cosméticos S.A. (BR) 2019-06-26 EP claimed
EP-3501491-A1 COSMETIC ANTI-BLEMISH COMPOSITION, USE OF THE COMPOSITION AND ANTI-BLEMISH TREATMENT METHOD Natura Cosméticos S.A. (BR) 2019-06-26 EP claimed
EP-2658610-B1 COLLOIDAL CARRIER SYSTEM WITH PENETRATION PROPERTIES FOR ENCAPSULATING LIPOPHILIC ACTIVE AGENTS AND OILS FOR TOPICAL USE BLUME GABRIELE (DE) 2016-05-04 EP claimed
US-20130184243-A1 COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF TREATING SKIN DISORDERS THEREWITH CEPTARIS THERAPEUTICS, INC. (US) 2013-07-18 US claimed
WO-2013009800-A2 COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF TREATING SKIN DISORDERS THEREWITH CEPTARIS THERAPEUTICS, INC. (US) 2013-01-17 WO claimed
EP-1148863-B2 DETERGENT COSMETIC COMPOSITIONS AND USE OREAL (FR) 2012-02-22 EP claimed
EP-2340805-A2 Holder system for enclosing lipophilic agents and oils in high concentrations Blume, Gabriele (DE) 2011-07-06 EP claimed
WO-2008048018-A1 A PHARMACEUTICALLY STABLE SUSPENSION OF MEGESTROL MATERIAL LG LIFE SCIENCES LTD. (KR) 2008-04-24 WO claimed
EP-1148863-B1 DETERGENT COSMETIC COMPOSITIONS AND USE OREAL (FR) 2002-06-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184243-A1 COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF TREATING SKIN DISORDERS THEREWITH MGMT, UNG, OGG1 OR51E2 3512/4885
US-20260137651-A1 MULTI-COMPARTMENT NANOEMULSION FOR INTRANASAL DRUG DELIVERY NAPEPLD, LIPA, SCD OR51E2 1425/4885
US-12599572-B2 Solid lipid nanoparticles of curcumin CPT1A, CPT2, SCD OR51E2 4738/4885
US-20240307352-A1 SACUBITRIL VALSARTAN SODIUM SUSTAINED-RELEASE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF VIP, SI, AGT OR51E2 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.